WMSA
NKTR icon

Weiss Multi-Strategy Advisers’s Nektar Therapeutics NKTR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-335
Closed -$306K – 556
2018
Q3 		$306K Sell
335
-332
-50% -$283K 0.01% 479
2018
Q2 		$488K Buy
667
+334
+100% +$385K 0.01% 489
2018
Q1 		$531K Buy
+333
New +$429K 0.02% 461
2013
Q3 		– Sell
-1,667
Closed -$289K – 965
2013
Q2 		$289K Buy
+1,667
New +$256K 0.01% 605

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Weiss Multi-Strategy Advisers's NKTR Position: Q4 2018 in Review

Weiss Multi-Strategy Advisers sold out of Nektar Therapeutics (NKTR) in Q4 2018, closing a stake of 335 shares — an estimated $306K sold.

Weiss Multi-Strategy Advisers first reported a position in NKTR in Q2 2013 and held it in 4 quarters. The position peaked at $531K in Q1 2018. 342 funds tracked by Wall St. Rank hold NKTR as of Q4 2018.

  • Weiss Multi-Strategy Advisers reported no remaining Nektar Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 335 Nektar Therapeutics shares in Q4 2018, an estimated $306K.
  • Weiss Multi-Strategy Advisers first reported a position in Nektar Therapeutics in Q2 2013 and held it in 4 quarters.
  • Weiss Multi-Strategy Advisers's Nektar Therapeutics position peaked at $531K in Q1 2018.
  • 342 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.